Timedora

5 Medication Safety, Complications, and Patient Education

Learn how impaired kidney function affects medication safety and how nursing care and patient education can help prevent complications.

How kidney dysfunction changes medication risk

The kidneys clear many medicines and their active metabolites. When kidney function declines, these substances may stay in the body longer and increase the risk of adverse effects or toxicity. Some medicines can also injure the kidneys.

Medication doses are not automatically changed for everyone or for every medicine. Decisions depend on the specific drug, kidney-function results, the patient’s clinical condition, and other factors. In , kidney function may change quickly, so a previously appropriate dose may need reassessment.

Nursing priorities for medication safety

should take place at admission, transfer, discharge, and follow-up. Compare the patient’s actual medication use with the record, including prescriptions, over-the-counter products, vitamins, supplements, and as-needed medicines. Identify duplicate products, possible interactions, and medicines without a current indication.

Connect medication doses to recent kidney-function results and trends, including eGFR and creatinine, rather than relying on a single result. Report acute changes and verify renal dosing with the prescriber or pharmacist, especially for medicines cleared by the kidneys or medicines with a narrow therapeutic range. During AKI, estimated kidney function may be unreliable because it is not at a steady state.

Monitor for intended effects as well as harm. Follow ordered laboratory tests, including creatinine, eGFR, and electrolytes, and check drug levels when indicated. Pay particular attention to potassium with some blood-pressure medicines, glucose with insulin or certain diabetes medicines, and bleeding risk with anticoagulants. Observe for new confusion, unusual sedation, weakness, or other suspected adverse effects.

Medication risks to recognize

such as ibuprofen and naproxen are common in pain relievers and some cold remedies. They can reduce kidney blood flow and contribute to kidney injury, particularly with dehydration or prolonged use. Encourage patients to check product labels and ask a clinician or pharmacist about safer options; do not recommend a substitute without considering the patient’s full clinical situation.

Some antibiotics, antivirals, diabetes medicines, and other may need a lower dose or longer interval as kidney function declines. The prescriber or pharmacist should confirm dosing based on the patient’s current kidney function.

ACE inhibitors and ARBs can raise potassium. Diuretics can contribute to dehydration or low potassium when the dose is not appropriate. These medicines can also provide important benefits, so patients should not stop or change them on their own. Monitoring and individualized clinical review are essential.

Fluid, urine, and kidney-injury changes

Measure intake and output when ordered, and note markedly reduced urine, new blood or persistent foam in urine, rapid weight gain, or swelling. Report these findings promptly. Reduced urine together with breathlessness or worsening edema may signal a serious complication.

Ask about recent vomiting, diarrhea, poor intake, infection, or low blood pressure, since these can contribute to dehydration and AKI. Follow the patient’s individualized fluid plan. Do not assume everyone should increase fluids, particularly when fluid restriction or heart failure is present.

Patient education and complication prevention

Encourage patients to keep an up-to-date medication list and bring it, or their medication containers, to appointments. Using one pharmacy when possible can support medication safety. Patients should check with a pharmacist or clinician before starting over-the-counter medicines, supplements, or herbal remedies, and take medicines as prescribed. They should not reduce, stop, or restart a medicine without following a clinician-approved plan.

Help each patient make a before an illness occurs. The patient and care team should identify which, if any, medicines may need temporary changes during vomiting, diarrhea, fever, or poor fluid intake, and when to restart them. Do not give blanket instructions to stop blood-pressure or kidney-protective medicines; the plan must be individualized.

Teach patients to promptly report substantially reduced urine, persistent vomiting or diarrhea, new swelling or shortness of breath, unusual bruising or bleeding, or symptoms of low blood sugar. Severe breathing difficulty, fainting, sudden confusion, or other rapidly worsening symptoms require urgent assessment.